Revenio is a Finnish, globally succesfully operating health technology corporation.

The focus of Revenio’s screening technology is on the early detection of glaucoma, osteoporosis, skin cancer and asthma, and the monitoring of these during the treatment process.

Revenio Group's core business is to develop and commercialize efficient and easily adopted health tech screening devices.

The common denominators of Revenio’s business operations include screening, follow-up and the global need to make cost savings through preventive health care. Revenio seeks vigorous growth in health technology.

Revenio's strong expertise in technology, strict quality criteria throughout the supply chain, and an understanding of different markets provide a strong basis for the company to be a global leader in healthtech-related screening devices in the future as well.

Continuous investment in research and product development will open up new opportunities for the Group and strengthen the market position of our existing products.

Image
Revenio Ventica

Business areas

Global leader in screening technologies

Revenio is a Finnish health tech group whose core business lies in tonometers for intraocular pressure screening. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy, Oscare Medical Oy and Revenio Research Oy.

In addition, Revenio has identified new growth opportunities relating to health tech in which common denominators are screening, follow-up and the global need to make cost savings in health care via preventive measures.

Revenio Group's core business is to develop and commercialize efficient and easily adopted health tech screening devices.

Strategy

A pioneer in its business

Our vision is to be the provider of choice for unique healtcare solutions for our customers and partners.

 

We enable easy and efficient diagnosis leading to highly satisfied and loyal customers.

 

We aspire to improve efficiency in diagnosis worldwide by providing unique and user-friendly medical instruments and solutions to healthcare professionals and patients.

 

We continue to strengthen our position in ophthalmology and expand our foundation and market reach with new product offering and knowledge in new applications and breakthrough technologies.

Image
Revenio Strategy

Image
Revenio Group Hero

Our people, network of experts, uncompromising commitment to quality and competitive products are the cornerstones for continued growth. We build our success through strong branding & IPR, world-class operations and selling through best channels & partners.

 

Health care is facing unprecedented global challenges. At the same time, the need for cost-effective health care is increasing. Innovations that enhance preventive health care and are easily available everywhere in the world increase the accessibility, quality, and productivity of health care.

 

Revenio’s objective is to become a leading global health technology company specializing in patient-led screening. In the field of preventive and cost-effective healthcare, the importance of patient-oriented screening is increasing with the aging population and with lesser national resources. What the health care sector needs is innovative tools that are easy to use and can be adopted worldwide at low cost. In this development Revenio wants to be a pioneer in its business.

Our vision is to be the provider of choice for unique healtcare solutions.

 

Our mission is to contribute better quality of life with our healthcare solutions enabling improved diagnosis.

Our values are

 
1

Trust & Integrity

 
2

People & Teamwork

3

Innovation & Quality

 
4

Growth & Value creation

 

Group structure

Revenio Group Corporation Corporate Governance structure

The Revenio Group comprises the parent company Revenio Group Corporation and its wholly or partly owned subsidiaries Icare Finland Oy, Icare USA Inc., Revenio Research Oy and Oscare Medical Oy.

The main product and the core business of Icare Finland is Icare tonometers for the measurement, monitoring, and screening of intraocular pressure as part of diagnosing glaucoma.

Revenio Research focuses on R&D projects with the objective of identifying and commercializing new health tech-related screening technologies.

Oscare Medical is developing and marketing a small and lightweight device for measuring bone strength and identifying people with an elevated risk of osteoporosis.

Image
Revenio Corporate Governance